nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluvastatin—UGT1A1—hematologic cancer	0.245	1	CbGaD
Fluvastatin—UGT1A1—Nilotinib—hematologic cancer	0.017	0.0345	CbGbCtD
Fluvastatin—UGT2B7—Epirubicin—hematologic cancer	0.0139	0.0282	CbGbCtD
Fluvastatin—CYP1A2—Anagrelide—hematologic cancer	0.0136	0.0277	CbGbCtD
Fluvastatin—CYP1A1—Methoxsalen—hematologic cancer	0.0136	0.0276	CbGbCtD
Fluvastatin—CYP2B6—Thiotepa—hematologic cancer	0.0133	0.0271	CbGbCtD
Fluvastatin—CYP1A1—Bortezomib—hematologic cancer	0.0129	0.0263	CbGbCtD
Fluvastatin—CYP1A1—Daunorubicin—hematologic cancer	0.0124	0.0252	CbGbCtD
Fluvastatin—UGT1A1—Irinotecan—hematologic cancer	0.0117	0.0237	CbGbCtD
Fluvastatin—CYP1A1—Thalidomide—hematologic cancer	0.0113	0.0229	CbGbCtD
Fluvastatin—CYP1A1—Dacarbazine—hematologic cancer	0.00969	0.0197	CbGbCtD
Fluvastatin—UGT1A1—Etoposide—hematologic cancer	0.00934	0.019	CbGbCtD
Fluvastatin—CYP2C9—Bexarotene—hematologic cancer	0.0085	0.0173	CbGbCtD
Fluvastatin—SLCO1B1—Irinotecan—hematologic cancer	0.00807	0.0164	CbGbCtD
Fluvastatin—CYP1A1—Dasatinib—hematologic cancer	0.00761	0.0155	CbGbCtD
Fluvastatin—CYP2B6—Ifosfamide—hematologic cancer	0.00756	0.0154	CbGbCtD
Fluvastatin—CYP2C8—Bortezomib—hematologic cancer	0.00747	0.0152	CbGbCtD
Fluvastatin—CYP3A5—Daunorubicin—hematologic cancer	0.00743	0.0151	CbGbCtD
Fluvastatin—SLCO1B3—Methotrexate—hematologic cancer	0.00734	0.0149	CbGbCtD
Fluvastatin—CYP2D6—Lomustine—hematologic cancer	0.00722	0.0147	CbGbCtD
Fluvastatin—CYP1A2—Carmustine—hematologic cancer	0.00715	0.0145	CbGbCtD
Fluvastatin—CYP2C9—Idarubicin—hematologic cancer	0.00704	0.0143	CbGbCtD
Fluvastatin—CYP3A5—Thalidomide—hematologic cancer	0.00676	0.0138	CbGbCtD
Fluvastatin—CYP2B6—Nilotinib—hematologic cancer	0.00656	0.0133	CbGbCtD
Fluvastatin—CYP3A5—Teniposide—hematologic cancer	0.00645	0.0131	CbGbCtD
Fluvastatin—CYP2D6—Idarubicin—hematologic cancer	0.00644	0.0131	CbGbCtD
Fluvastatin—CYP2C19—Bortezomib—hematologic cancer	0.00626	0.0127	CbGbCtD
Fluvastatin—CYP1A2—Methoxsalen—hematologic cancer	0.00608	0.0124	CbGbCtD
Fluvastatin—CYP3A5—Ifosfamide—hematologic cancer	0.00596	0.0121	CbGbCtD
Fluvastatin—CYP1A2—Bortezomib—hematologic cancer	0.00578	0.0117	CbGbCtD
Fluvastatin—CYP2C8—Ifosfamide—hematologic cancer	0.00573	0.0116	CbGbCtD
Fluvastatin—CYP3A5—Imatinib—hematologic cancer	0.00569	0.0116	CbGbCtD
Fluvastatin—CYP1A2—Daunorubicin—hematologic cancer	0.00553	0.0112	CbGbCtD
Fluvastatin—CYP2D6—Hydroxyurea—hematologic cancer	0.00547	0.0111	CbGbCtD
Fluvastatin—CYP2C19—Thalidomide—hematologic cancer	0.00546	0.0111	CbGbCtD
Fluvastatin—CYP1A2—Alitretinoin—hematologic cancer	0.00542	0.011	CbGbCtD
Fluvastatin—CYP2C9—Bortezomib—hematologic cancer	0.00521	0.0106	CbGbCtD
Fluvastatin—CYP2C19—Teniposide—hematologic cancer	0.00521	0.0106	CbGbCtD
Fluvastatin—CYP1A2—Thalidomide—hematologic cancer	0.00503	0.0102	CbGbCtD
Fluvastatin—CYP2C8—Nilotinib—hematologic cancer	0.00497	0.0101	CbGbCtD
Fluvastatin—CYP3A4—Bexarotene—hematologic cancer	0.00494	0.01	CbGbCtD
Fluvastatin—CYP2C19—Ifosfamide—hematologic cancer	0.0048	0.00976	CbGbCtD
Fluvastatin—CYP2D6—Bortezomib—hematologic cancer	0.00476	0.00968	CbGbCtD
Fluvastatin—CYP3A4—Lomustine—hematologic cancer	0.00459	0.00934	CbGbCtD
Fluvastatin—CYP3A4—Busulfan—hematologic cancer	0.00459	0.00934	CbGbCtD
Fluvastatin—CYP2C19—Imatinib—hematologic cancer	0.00459	0.00933	CbGbCtD
Fluvastatin—CYP3A5—Dasatinib—hematologic cancer	0.00457	0.00929	CbGbCtD
Fluvastatin—CYP2C9—Thalidomide—hematologic cancer	0.00454	0.00922	CbGbCtD
Fluvastatin—CYP2B6—Irinotecan—hematologic cancer	0.00451	0.00917	CbGbCtD
Fluvastatin—CYP1A2—Dacarbazine—hematologic cancer	0.00433	0.0088	CbGbCtD
Fluvastatin—CYP2C9—Teniposide—hematologic cancer	0.00433	0.0088	CbGbCtD
Fluvastatin—SLCO1B1—Methotrexate—hematologic cancer	0.00427	0.00868	CbGbCtD
Fluvastatin—CYP1A2—Imatinib—hematologic cancer	0.00423	0.00861	CbGbCtD
Fluvastatin—CYP3A4—Thiotepa—hematologic cancer	0.00409	0.00832	CbGbCtD
Fluvastatin—CYP2C9—Ifosfamide—hematologic cancer	0.00399	0.00812	CbGbCtD
Fluvastatin—CYP1A1—Dexamethasone—hematologic cancer	0.0039	0.00792	CbGbCtD
Fluvastatin—CYP2C9—Imatinib—hematologic cancer	0.00382	0.00776	CbGbCtD
Fluvastatin—CYP2B6—Cisplatin—hematologic cancer	0.00368	0.00747	CbGbCtD
Fluvastatin—CYP3A5—Irinotecan—hematologic cancer	0.00355	0.00722	CbGbCtD
Fluvastatin—CYP2D6—Imatinib—hematologic cancer	0.00349	0.00709	CbGbCtD
Fluvastatin—CYP2C9—Nilotinib—hematologic cancer	0.00347	0.00705	CbGbCtD
Fluvastatin—CYP1A2—Dasatinib—hematologic cancer	0.0034	0.00691	CbGbCtD
Fluvastatin—CYP3A4—Methoxsalen—hematologic cancer	0.00318	0.00647	CbGbCtD
Fluvastatin—CYP2D6—Nilotinib—hematologic cancer	0.00317	0.00644	CbGbCtD
Fluvastatin—CYP2D6—Vinorelbine—hematologic cancer	0.00314	0.00639	CbGbCtD
Fluvastatin—CYP3A5—Vincristine—hematologic cancer	0.00311	0.00631	CbGbCtD
Fluvastatin—CYP3A4—Bortezomib—hematologic cancer	0.00303	0.00615	CbGbCtD
Fluvastatin—CYP2C19—Prednisone—hematologic cancer	0.00302	0.00615	CbGbCtD
Fluvastatin—CYP2B6—Dexamethasone—hematologic cancer	0.00297	0.00604	CbGbCtD
Fluvastatin—CYP3A4—Daunorubicin—hematologic cancer	0.0029	0.00589	CbGbCtD
Fluvastatin—CYP3A5—Etoposide—hematologic cancer	0.00285	0.00579	CbGbCtD
Fluvastatin—CYP2C8—Etoposide—hematologic cancer	0.00274	0.00556	CbGbCtD
Fluvastatin—CYP3A4—Cytarabine—hematologic cancer	0.00255	0.00519	CbGbCtD
Fluvastatin—CYP3A4—Teniposide—hematologic cancer	0.00252	0.00512	CbGbCtD
Fluvastatin—CYP2B6—Doxorubicin—hematologic cancer	0.00246	0.00501	CbGbCtD
Fluvastatin—CYP3A5—Dexamethasone—hematologic cancer	0.00234	0.00476	CbGbCtD
Fluvastatin—CYP3A4—Ifosfamide—hematologic cancer	0.00232	0.00472	CbGbCtD
Fluvastatin—CYP2C8—Dexamethasone—hematologic cancer	0.00225	0.00457	CbGbCtD
Fluvastatin—CYP3A4—Imatinib—hematologic cancer	0.00222	0.00451	CbGbCtD
Fluvastatin—CYP1A2—Etoposide—hematologic cancer	0.00212	0.00431	CbGbCtD
Fluvastatin—CYP3A4—Ruxolitinib—hematologic cancer	0.00209	0.00425	CbGbCtD
Fluvastatin—CYP3A4—Nilotinib—hematologic cancer	0.00202	0.0041	CbGbCtD
Fluvastatin—CYP3A4—Vinorelbine—hematologic cancer	0.002	0.00406	CbGbCtD
Fluvastatin—CYP2C9—Cisplatin—hematologic cancer	0.00194	0.00395	CbGbCtD
Fluvastatin—CYP2D6—Vinblastine—hematologic cancer	0.00194	0.00394	CbGbCtD
Fluvastatin—CYP2C19—Dexamethasone—hematologic cancer	0.00189	0.00384	CbGbCtD
Fluvastatin—CYP3A4—Triamcinolone—hematologic cancer	0.00183	0.00372	CbGbCtD
Fluvastatin—CYP3A4—Dasatinib—hematologic cancer	0.00178	0.00362	CbGbCtD
Fluvastatin—CYP3A4—Mitoxantrone—hematologic cancer	0.00176	0.00358	CbGbCtD
Fluvastatin—CYP2C9—Dexamethasone—hematologic cancer	0.00157	0.00319	CbGbCtD
Fluvastatin—CYP3A4—Betamethasone—hematologic cancer	0.00157	0.00319	CbGbCtD
Fluvastatin—CYP3A4—Prednisolone—hematologic cancer	0.00155	0.00315	CbGbCtD
Fluvastatin—CYP3A4—Prednisone—hematologic cancer	0.00146	0.00297	CbGbCtD
Fluvastatin—CYP2D6—Dexamethasone—hematologic cancer	0.00144	0.00292	CbGbCtD
Fluvastatin—CYP3A4—Irinotecan—hematologic cancer	0.00139	0.00282	CbGbCtD
Fluvastatin—CYP3A4—Vinblastine—hematologic cancer	0.00123	0.0025	CbGbCtD
Fluvastatin—CYP3A4—Vincristine—hematologic cancer	0.00121	0.00246	CbGbCtD
Fluvastatin—CYP2D6—Doxorubicin—hematologic cancer	0.00119	0.00242	CbGbCtD
Fluvastatin—CYP3A4—Etoposide—hematologic cancer	0.00111	0.00226	CbGbCtD
Fluvastatin—UGT1A1—hematopoietic system—hematologic cancer	0.00103	0.053	CbGeAlD
Fluvastatin—CYP3A4—Dexamethasone—hematologic cancer	0.000913	0.00185	CbGbCtD
Fluvastatin—HMGCR—hematopoietic system—hematologic cancer	0.000898	0.0461	CbGeAlD
Fluvastatin—SLCO1B3—lung—hematologic cancer	0.000864	0.0443	CbGeAlD
Fluvastatin—SLCO1B1—hematopoietic system—hematologic cancer	0.00086	0.0441	CbGeAlD
Fluvastatin—SLCO2B1—hematopoietic system—hematologic cancer	0.00076	0.039	CbGeAlD
Fluvastatin—CYP3A4—Doxorubicin—hematologic cancer	0.000757	0.00154	CbGbCtD
Fluvastatin—UGT1A1—blood—hematologic cancer	0.000685	0.0351	CbGeAlD
Fluvastatin—HMGCR—gonad—hematologic cancer	0.000682	0.035	CbGeAlD
Fluvastatin—Atorvastatin—UGT1A1—hematologic cancer	0.000673	0.272	CrCbGaD
Fluvastatin—UGT2B7—testis—hematologic cancer	0.000666	0.0342	CbGeAlD
Fluvastatin—HMGCR—blood—hematologic cancer	0.000595	0.0305	CbGeAlD
Fluvastatin—HMGCR—bone marrow—hematologic cancer	0.000575	0.0295	CbGeAlD
Fluvastatin—SLCO1B1—blood—hematologic cancer	0.00057	0.0292	CbGeAlD
Fluvastatin—CYP2C19—hematopoietic system—hematologic cancer	0.00056	0.0287	CbGeAlD
Fluvastatin—Rosuvastatin—ABCG2—hematologic cancer	0.000537	0.217	CrCbGaD
Fluvastatin—HMGCR—lung—hematologic cancer	0.000521	0.0267	CbGeAlD
Fluvastatin—HMGCR—testis—hematologic cancer	0.000492	0.0252	CbGeAlD
Fluvastatin—CYP2C8—hematopoietic system—hematologic cancer	0.000489	0.0251	CbGeAlD
Fluvastatin—Pitavastatin—ABCG2—hematologic cancer	0.000469	0.19	CrCbGaD
Fluvastatin—CYP1A2—hematopoietic system—hematologic cancer	0.000458	0.0235	CbGeAlD
Fluvastatin—CYP1A1—hematopoietic system—hematologic cancer	0.000451	0.0232	CbGeAlD
Fluvastatin—SLCO2B1—lung—hematologic cancer	0.000442	0.0227	CbGeAlD
Fluvastatin—CYP3A5—hematopoietic system—hematologic cancer	0.000441	0.0226	CbGeAlD
Fluvastatin—CYP2B6—hematopoietic system—hematologic cancer	0.000439	0.0225	CbGeAlD
Fluvastatin—CYP2C9—hematopoietic system—hematologic cancer	0.000434	0.0223	CbGeAlD
Fluvastatin—SLCO2B1—testis—hematologic cancer	0.000417	0.0214	CbGeAlD
Fluvastatin—CYP2C19—blood—hematologic cancer	0.000371	0.019	CbGeAlD
Fluvastatin—HMGCR—lymph node—hematologic cancer	0.000357	0.0183	CbGeAlD
Fluvastatin—CYP2B6—gonad—hematologic cancer	0.000333	0.0171	CbGeAlD
Fluvastatin—CYP3A4—hematopoietic system—hematologic cancer	0.000331	0.017	CbGeAlD
Fluvastatin—CYP2D6—hematopoietic system—hematologic cancer	0.000326	0.0167	CbGeAlD
Fluvastatin—CYP2C8—blood—hematologic cancer	0.000324	0.0166	CbGeAlD
Fluvastatin—CYP1A2—blood—hematologic cancer	0.000303	0.0156	CbGeAlD
Fluvastatin—SLCO2B1—lymph node—hematologic cancer	0.000302	0.0155	CbGeAlD
Fluvastatin—CYP1A1—blood—hematologic cancer	0.000299	0.0153	CbGeAlD
Fluvastatin—CYP3A5—blood—hematologic cancer	0.000292	0.015	CbGeAlD
Fluvastatin—CYP2B6—blood—hematologic cancer	0.000291	0.0149	CbGeAlD
Fluvastatin—CYP2C9—blood—hematologic cancer	0.000288	0.0148	CbGeAlD
Fluvastatin—CYP2C8—testis—hematologic cancer	0.000268	0.0137	CbGeAlD
Fluvastatin—CYP1A2—lung—hematologic cancer	0.000266	0.0136	CbGeAlD
Fluvastatin—CYP1A1—lung—hematologic cancer	0.000262	0.0135	CbGeAlD
Fluvastatin—CYP3A5—lung—hematologic cancer	0.000256	0.0132	CbGeAlD
Fluvastatin—CYP2B6—lung—hematologic cancer	0.000255	0.0131	CbGeAlD
Fluvastatin—CYP2B6—testis—hematologic cancer	0.00024	0.0123	CbGeAlD
Fluvastatin—Rosuvastatin—ALB—hematologic cancer	0.000234	0.0948	CrCbGaD
Fluvastatin—CYP3A4—blood—hematologic cancer	0.000219	0.0113	CbGeAlD
Fluvastatin—CYP2D6—blood—hematologic cancer	0.000216	0.0111	CbGeAlD
Fluvastatin—Pitavastatin—ALB—hematologic cancer	0.000205	0.0828	CrCbGaD
Fluvastatin—Pitavastatin—ABCB1—hematologic cancer	0.000195	0.0791	CrCbGaD
Fluvastatin—CYP1A1—lymph node—hematologic cancer	0.000179	0.0092	CbGeAlD
Fluvastatin—CYP2D6—testis—hematologic cancer	0.000179	0.00916	CbGeAlD
Fluvastatin—Atorvastatin—ABCB1—hematologic cancer	0.000157	0.0637	CrCbGaD
Fluvastatin—Gastrointestinal disorder—Betamethasone—hematologic cancer	2.06e-05	0.000115	CcSEcCtD
Fluvastatin—Back pain—Methotrexate—hematologic cancer	2.05e-05	0.000115	CcSEcCtD
Fluvastatin—Fatigue—Dexamethasone—hematologic cancer	2.05e-05	0.000115	CcSEcCtD
Fluvastatin—Fatigue—Betamethasone—hematologic cancer	2.05e-05	0.000115	CcSEcCtD
Fluvastatin—Chills—Epirubicin—hematologic cancer	2.05e-05	0.000115	CcSEcCtD
Fluvastatin—Pruritus—Etoposide—hematologic cancer	2.05e-05	0.000114	CcSEcCtD
Fluvastatin—Shock—Prednisone—hematologic cancer	2.04e-05	0.000114	CcSEcCtD
Fluvastatin—Arrhythmia—Epirubicin—hematologic cancer	2.04e-05	0.000114	CcSEcCtD
Fluvastatin—Pain—Betamethasone—hematologic cancer	2.04e-05	0.000114	CcSEcCtD
Fluvastatin—Pain—Dexamethasone—hematologic cancer	2.04e-05	0.000114	CcSEcCtD
Fluvastatin—Visual impairment—Doxorubicin—hematologic cancer	2.04e-05	0.000114	CcSEcCtD
Fluvastatin—Nervous system disorder—Prednisone—hematologic cancer	2.03e-05	0.000114	CcSEcCtD
Fluvastatin—Alopecia—Epirubicin—hematologic cancer	2.02e-05	0.000113	CcSEcCtD
Fluvastatin—Skin disorder—Prednisone—hematologic cancer	2.01e-05	0.000113	CcSEcCtD
Fluvastatin—Nausea—Gemcitabine—hematologic cancer	2.01e-05	0.000113	CcSEcCtD
Fluvastatin—Vomiting—Cisplatin—hematologic cancer	2.01e-05	0.000112	CcSEcCtD
Fluvastatin—Hyperhidrosis—Prednisone—hematologic cancer	2e-05	0.000112	CcSEcCtD
Fluvastatin—Mental disorder—Epirubicin—hematologic cancer	2e-05	0.000112	CcSEcCtD
Fluvastatin—Erythema multiforme—Doxorubicin—hematologic cancer	2e-05	0.000112	CcSEcCtD
Fluvastatin—Rash—Cisplatin—hematologic cancer	1.99e-05	0.000111	CcSEcCtD
Fluvastatin—Dermatitis—Cisplatin—hematologic cancer	1.99e-05	0.000111	CcSEcCtD
Fluvastatin—Erythema—Epirubicin—hematologic cancer	1.99e-05	0.000111	CcSEcCtD
Fluvastatin—Diarrhoea—Etoposide—hematologic cancer	1.98e-05	0.000111	CcSEcCtD
Fluvastatin—Anorexia—Prednisone—hematologic cancer	1.98e-05	0.000111	CcSEcCtD
Fluvastatin—Ill-defined disorder—Methotrexate—hematologic cancer	1.97e-05	0.00011	CcSEcCtD
Fluvastatin—Feeling abnormal—Dexamethasone—hematologic cancer	1.96e-05	0.00011	CcSEcCtD
Fluvastatin—Feeling abnormal—Betamethasone—hematologic cancer	1.96e-05	0.00011	CcSEcCtD
Fluvastatin—Flushing—Doxorubicin—hematologic cancer	1.96e-05	0.00011	CcSEcCtD
Fluvastatin—Cardiac disorder—Doxorubicin—hematologic cancer	1.96e-05	0.00011	CcSEcCtD
Fluvastatin—Flatulence—Epirubicin—hematologic cancer	1.96e-05	0.000109	CcSEcCtD
Fluvastatin—Gastrointestinal pain—Betamethasone—hematologic cancer	1.95e-05	0.000109	CcSEcCtD
Fluvastatin—Gastrointestinal pain—Dexamethasone—hematologic cancer	1.95e-05	0.000109	CcSEcCtD
Fluvastatin—Dysgeusia—Epirubicin—hematologic cancer	1.95e-05	0.000109	CcSEcCtD
Fluvastatin—Hypersensitivity—Triamcinolone—hematologic cancer	1.93e-05	0.000108	CcSEcCtD
Fluvastatin—Back pain—Epirubicin—hematologic cancer	1.92e-05	0.000107	CcSEcCtD
Fluvastatin—Angiopathy—Doxorubicin—hematologic cancer	1.92e-05	0.000107	CcSEcCtD
Fluvastatin—Malaise—Methotrexate—hematologic cancer	1.91e-05	0.000107	CcSEcCtD
Fluvastatin—Dizziness—Etoposide—hematologic cancer	1.91e-05	0.000107	CcSEcCtD
Fluvastatin—Muscle spasms—Epirubicin—hematologic cancer	1.91e-05	0.000107	CcSEcCtD
Fluvastatin—Immune system disorder—Doxorubicin—hematologic cancer	1.91e-05	0.000107	CcSEcCtD
Fluvastatin—Vertigo—Methotrexate—hematologic cancer	1.91e-05	0.000107	CcSEcCtD
Fluvastatin—Leukopenia—Methotrexate—hematologic cancer	1.9e-05	0.000106	CcSEcCtD
Fluvastatin—Chills—Doxorubicin—hematologic cancer	1.9e-05	0.000106	CcSEcCtD
Fluvastatin—Urticaria—Dexamethasone—hematologic cancer	1.89e-05	0.000106	CcSEcCtD
Fluvastatin—Urticaria—Betamethasone—hematologic cancer	1.89e-05	0.000106	CcSEcCtD
Fluvastatin—Musculoskeletal discomfort—Prednisone—hematologic cancer	1.89e-05	0.000106	CcSEcCtD
Fluvastatin—Dizziness—Prednisolone—hematologic cancer	1.89e-05	0.000106	CcSEcCtD
Fluvastatin—Arrhythmia—Doxorubicin—hematologic cancer	1.89e-05	0.000105	CcSEcCtD
Fluvastatin—Asthenia—Triamcinolone—hematologic cancer	1.88e-05	0.000105	CcSEcCtD
Fluvastatin—Abdominal pain—Dexamethasone—hematologic cancer	1.88e-05	0.000105	CcSEcCtD
Fluvastatin—Abdominal pain—Betamethasone—hematologic cancer	1.88e-05	0.000105	CcSEcCtD
Fluvastatin—Body temperature increased—Betamethasone—hematologic cancer	1.88e-05	0.000105	CcSEcCtD
Fluvastatin—Body temperature increased—Dexamethasone—hematologic cancer	1.88e-05	0.000105	CcSEcCtD
Fluvastatin—Nausea—Cisplatin—hematologic cancer	1.88e-05	0.000105	CcSEcCtD
Fluvastatin—Insomnia—Prednisone—hematologic cancer	1.88e-05	0.000105	CcSEcCtD
Fluvastatin—Alopecia—Doxorubicin—hematologic cancer	1.87e-05	0.000104	CcSEcCtD
Fluvastatin—Paraesthesia—Prednisone—hematologic cancer	1.86e-05	0.000104	CcSEcCtD
Fluvastatin—Pruritus—Triamcinolone—hematologic cancer	1.86e-05	0.000104	CcSEcCtD
Fluvastatin—Cough—Methotrexate—hematologic cancer	1.85e-05	0.000104	CcSEcCtD
Fluvastatin—Mental disorder—Doxorubicin—hematologic cancer	1.85e-05	0.000103	CcSEcCtD
Fluvastatin—Ill-defined disorder—Epirubicin—hematologic cancer	1.84e-05	0.000103	CcSEcCtD
Fluvastatin—Vomiting—Etoposide—hematologic cancer	1.84e-05	0.000103	CcSEcCtD
Fluvastatin—Erythema—Doxorubicin—hematologic cancer	1.84e-05	0.000103	CcSEcCtD
Fluvastatin—Dyspepsia—Prednisone—hematologic cancer	1.83e-05	0.000102	CcSEcCtD
Fluvastatin—Rash—Etoposide—hematologic cancer	1.82e-05	0.000102	CcSEcCtD
Fluvastatin—Dermatitis—Etoposide—hematologic cancer	1.82e-05	0.000102	CcSEcCtD
Fluvastatin—Headache—Etoposide—hematologic cancer	1.81e-05	0.000101	CcSEcCtD
Fluvastatin—Flatulence—Doxorubicin—hematologic cancer	1.81e-05	0.000101	CcSEcCtD
Fluvastatin—Arthralgia—Methotrexate—hematologic cancer	1.81e-05	0.000101	CcSEcCtD
Fluvastatin—Chest pain—Methotrexate—hematologic cancer	1.81e-05	0.000101	CcSEcCtD
Fluvastatin—Myalgia—Methotrexate—hematologic cancer	1.81e-05	0.000101	CcSEcCtD
Fluvastatin—Decreased appetite—Prednisone—hematologic cancer	1.8e-05	0.000101	CcSEcCtD
Fluvastatin—Dysgeusia—Doxorubicin—hematologic cancer	1.8e-05	0.000101	CcSEcCtD
Fluvastatin—Rash—Prednisolone—hematologic cancer	1.8e-05	0.000101	CcSEcCtD
Fluvastatin—Dermatitis—Prednisolone—hematologic cancer	1.8e-05	0.000101	CcSEcCtD
Fluvastatin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	1.8e-05	0.0001	CcSEcCtD
Fluvastatin—Malaise—Epirubicin—hematologic cancer	1.79e-05	0.0001	CcSEcCtD
Fluvastatin—Fatigue—Prednisone—hematologic cancer	1.79e-05	0.0001	CcSEcCtD
Fluvastatin—Headache—Prednisolone—hematologic cancer	1.79e-05	0.0001	CcSEcCtD
Fluvastatin—Discomfort—Methotrexate—hematologic cancer	1.79e-05	9.99e-05	CcSEcCtD
Fluvastatin—Vertigo—Epirubicin—hematologic cancer	1.79e-05	9.98e-05	CcSEcCtD
Fluvastatin—Syncope—Epirubicin—hematologic cancer	1.78e-05	9.96e-05	CcSEcCtD
Fluvastatin—Leukopenia—Epirubicin—hematologic cancer	1.78e-05	9.95e-05	CcSEcCtD
Fluvastatin—Back pain—Doxorubicin—hematologic cancer	1.78e-05	9.94e-05	CcSEcCtD
Fluvastatin—Constipation—Prednisone—hematologic cancer	1.77e-05	9.91e-05	CcSEcCtD
Fluvastatin—Muscle spasms—Doxorubicin—hematologic cancer	1.77e-05	9.88e-05	CcSEcCtD
Fluvastatin—Confusional state—Methotrexate—hematologic cancer	1.75e-05	9.77e-05	CcSEcCtD
Fluvastatin—Loss of consciousness—Epirubicin—hematologic cancer	1.75e-05	9.77e-05	CcSEcCtD
Fluvastatin—Dizziness—Triamcinolone—hematologic cancer	1.74e-05	9.7e-05	CcSEcCtD
Fluvastatin—Cough—Epirubicin—hematologic cancer	1.73e-05	9.7e-05	CcSEcCtD
Fluvastatin—Anaphylactic shock—Methotrexate—hematologic cancer	1.73e-05	9.69e-05	CcSEcCtD
Fluvastatin—Infection—Methotrexate—hematologic cancer	1.72e-05	9.63e-05	CcSEcCtD
Fluvastatin—Nausea—Etoposide—hematologic cancer	1.72e-05	9.61e-05	CcSEcCtD
Fluvastatin—Hypertension—Epirubicin—hematologic cancer	1.72e-05	9.59e-05	CcSEcCtD
Fluvastatin—Feeling abnormal—Prednisone—hematologic cancer	1.71e-05	9.55e-05	CcSEcCtD
Fluvastatin—Asthenia—Dexamethasone—hematologic cancer	1.71e-05	9.55e-05	CcSEcCtD
Fluvastatin—Asthenia—Betamethasone—hematologic cancer	1.71e-05	9.55e-05	CcSEcCtD
Fluvastatin—Ill-defined disorder—Doxorubicin—hematologic cancer	1.71e-05	9.54e-05	CcSEcCtD
Fluvastatin—Nervous system disorder—Methotrexate—hematologic cancer	1.7e-05	9.5e-05	CcSEcCtD
Fluvastatin—Thrombocytopenia—Methotrexate—hematologic cancer	1.7e-05	9.49e-05	CcSEcCtD
Fluvastatin—Gastrointestinal pain—Prednisone—hematologic cancer	1.7e-05	9.48e-05	CcSEcCtD
Fluvastatin—Nausea—Prednisolone—hematologic cancer	1.69e-05	9.48e-05	CcSEcCtD
Fluvastatin—Chest pain—Epirubicin—hematologic cancer	1.69e-05	9.46e-05	CcSEcCtD
Fluvastatin—Myalgia—Epirubicin—hematologic cancer	1.69e-05	9.46e-05	CcSEcCtD
Fluvastatin—Arthralgia—Epirubicin—hematologic cancer	1.69e-05	9.46e-05	CcSEcCtD
Fluvastatin—Anxiety—Epirubicin—hematologic cancer	1.69e-05	9.43e-05	CcSEcCtD
Fluvastatin—Pruritus—Dexamethasone—hematologic cancer	1.68e-05	9.42e-05	CcSEcCtD
Fluvastatin—Pruritus—Betamethasone—hematologic cancer	1.68e-05	9.42e-05	CcSEcCtD
Fluvastatin—Skin disorder—Methotrexate—hematologic cancer	1.68e-05	9.41e-05	CcSEcCtD
Fluvastatin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	1.68e-05	9.39e-05	CcSEcCtD
Fluvastatin—Hyperhidrosis—Methotrexate—hematologic cancer	1.68e-05	9.37e-05	CcSEcCtD
Fluvastatin—Discomfort—Epirubicin—hematologic cancer	1.67e-05	9.35e-05	CcSEcCtD
Fluvastatin—Vomiting—Triamcinolone—hematologic cancer	1.67e-05	9.33e-05	CcSEcCtD
Fluvastatin—Malaise—Doxorubicin—hematologic cancer	1.66e-05	9.27e-05	CcSEcCtD
Fluvastatin—Rash—Triamcinolone—hematologic cancer	1.65e-05	9.25e-05	CcSEcCtD
Fluvastatin—Dermatitis—Triamcinolone—hematologic cancer	1.65e-05	9.24e-05	CcSEcCtD
Fluvastatin—Vertigo—Doxorubicin—hematologic cancer	1.65e-05	9.24e-05	CcSEcCtD
Fluvastatin—Anorexia—Methotrexate—hematologic cancer	1.65e-05	9.24e-05	CcSEcCtD
Fluvastatin—Syncope—Doxorubicin—hematologic cancer	1.65e-05	9.22e-05	CcSEcCtD
Fluvastatin—Urticaria—Prednisone—hematologic cancer	1.65e-05	9.21e-05	CcSEcCtD
Fluvastatin—Leukopenia—Doxorubicin—hematologic cancer	1.65e-05	9.2e-05	CcSEcCtD
Fluvastatin—Headache—Triamcinolone—hematologic cancer	1.64e-05	9.19e-05	CcSEcCtD
Fluvastatin—Abdominal pain—Prednisone—hematologic cancer	1.64e-05	9.17e-05	CcSEcCtD
Fluvastatin—Body temperature increased—Prednisone—hematologic cancer	1.64e-05	9.17e-05	CcSEcCtD
Fluvastatin—Confusional state—Epirubicin—hematologic cancer	1.64e-05	9.14e-05	CcSEcCtD
Fluvastatin—Diarrhoea—Dexamethasone—hematologic cancer	1.63e-05	9.11e-05	CcSEcCtD
Fluvastatin—Diarrhoea—Betamethasone—hematologic cancer	1.63e-05	9.11e-05	CcSEcCtD
Fluvastatin—Anaphylactic shock—Epirubicin—hematologic cancer	1.62e-05	9.07e-05	CcSEcCtD
Fluvastatin—Loss of consciousness—Doxorubicin—hematologic cancer	1.62e-05	9.04e-05	CcSEcCtD
Fluvastatin—Infection—Epirubicin—hematologic cancer	1.61e-05	9.01e-05	CcSEcCtD
Fluvastatin—Cough—Doxorubicin—hematologic cancer	1.6e-05	8.97e-05	CcSEcCtD
Fluvastatin—Shock—Epirubicin—hematologic cancer	1.6e-05	8.92e-05	CcSEcCtD
Fluvastatin—Nervous system disorder—Epirubicin—hematologic cancer	1.59e-05	8.89e-05	CcSEcCtD
Fluvastatin—Thrombocytopenia—Epirubicin—hematologic cancer	1.59e-05	8.88e-05	CcSEcCtD
Fluvastatin—Hypertension—Doxorubicin—hematologic cancer	1.59e-05	8.88e-05	CcSEcCtD
Fluvastatin—Musculoskeletal discomfort—Methotrexate—hematologic cancer	1.58e-05	8.83e-05	CcSEcCtD
Fluvastatin—Skin disorder—Epirubicin—hematologic cancer	1.58e-05	8.81e-05	CcSEcCtD
Fluvastatin—Dizziness—Betamethasone—hematologic cancer	1.57e-05	8.8e-05	CcSEcCtD
Fluvastatin—Dizziness—Dexamethasone—hematologic cancer	1.57e-05	8.8e-05	CcSEcCtD
Fluvastatin—Hyperhidrosis—Epirubicin—hematologic cancer	1.57e-05	8.77e-05	CcSEcCtD
Fluvastatin—Insomnia—Methotrexate—hematologic cancer	1.57e-05	8.76e-05	CcSEcCtD
Fluvastatin—Myalgia—Doxorubicin—hematologic cancer	1.57e-05	8.75e-05	CcSEcCtD
Fluvastatin—Arthralgia—Doxorubicin—hematologic cancer	1.57e-05	8.75e-05	CcSEcCtD
Fluvastatin—Chest pain—Doxorubicin—hematologic cancer	1.57e-05	8.75e-05	CcSEcCtD
Fluvastatin—Anxiety—Doxorubicin—hematologic cancer	1.56e-05	8.72e-05	CcSEcCtD
Fluvastatin—Nausea—Triamcinolone—hematologic cancer	1.56e-05	8.72e-05	CcSEcCtD
Fluvastatin—Paraesthesia—Methotrexate—hematologic cancer	1.56e-05	8.7e-05	CcSEcCtD
Fluvastatin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	1.55e-05	8.69e-05	CcSEcCtD
Fluvastatin—Discomfort—Doxorubicin—hematologic cancer	1.55e-05	8.65e-05	CcSEcCtD
Fluvastatin—Anorexia—Epirubicin—hematologic cancer	1.55e-05	8.64e-05	CcSEcCtD
Fluvastatin—Dyspnoea—Methotrexate—hematologic cancer	1.54e-05	8.64e-05	CcSEcCtD
Fluvastatin—Hypersensitivity—Prednisone—hematologic cancer	1.53e-05	8.54e-05	CcSEcCtD
Fluvastatin—Dyspepsia—Methotrexate—hematologic cancer	1.53e-05	8.53e-05	CcSEcCtD
Fluvastatin—Vomiting—Dexamethasone—hematologic cancer	1.51e-05	8.46e-05	CcSEcCtD
Fluvastatin—Vomiting—Betamethasone—hematologic cancer	1.51e-05	8.46e-05	CcSEcCtD
Fluvastatin—Confusional state—Doxorubicin—hematologic cancer	1.51e-05	8.46e-05	CcSEcCtD
Fluvastatin—Decreased appetite—Methotrexate—hematologic cancer	1.51e-05	8.42e-05	CcSEcCtD
Fluvastatin—Rash—Dexamethasone—hematologic cancer	1.5e-05	8.39e-05	CcSEcCtD
Fluvastatin—Rash—Betamethasone—hematologic cancer	1.5e-05	8.39e-05	CcSEcCtD
Fluvastatin—Anaphylactic shock—Doxorubicin—hematologic cancer	1.5e-05	8.39e-05	CcSEcCtD
Fluvastatin—Dermatitis—Betamethasone—hematologic cancer	1.5e-05	8.39e-05	CcSEcCtD
Fluvastatin—Dermatitis—Dexamethasone—hematologic cancer	1.5e-05	8.39e-05	CcSEcCtD
Fluvastatin—Gastrointestinal disorder—Methotrexate—hematologic cancer	1.5e-05	8.37e-05	CcSEcCtD
Fluvastatin—Fatigue—Methotrexate—hematologic cancer	1.49e-05	8.35e-05	CcSEcCtD
Fluvastatin—Headache—Betamethasone—hematologic cancer	1.49e-05	8.34e-05	CcSEcCtD
Fluvastatin—Headache—Dexamethasone—hematologic cancer	1.49e-05	8.34e-05	CcSEcCtD
Fluvastatin—Infection—Doxorubicin—hematologic cancer	1.49e-05	8.34e-05	CcSEcCtD
Fluvastatin—Asthenia—Prednisone—hematologic cancer	1.49e-05	8.32e-05	CcSEcCtD
Fluvastatin—Pain—Methotrexate—hematologic cancer	1.48e-05	8.29e-05	CcSEcCtD
Fluvastatin—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.48e-05	8.26e-05	CcSEcCtD
Fluvastatin—Shock—Doxorubicin—hematologic cancer	1.48e-05	8.25e-05	CcSEcCtD
Fluvastatin—Nervous system disorder—Doxorubicin—hematologic cancer	1.47e-05	8.23e-05	CcSEcCtD
Fluvastatin—Thrombocytopenia—Doxorubicin—hematologic cancer	1.47e-05	8.21e-05	CcSEcCtD
Fluvastatin—Pruritus—Prednisone—hematologic cancer	1.47e-05	8.2e-05	CcSEcCtD
Fluvastatin—Insomnia—Epirubicin—hematologic cancer	1.47e-05	8.2e-05	CcSEcCtD
Fluvastatin—Skin disorder—Doxorubicin—hematologic cancer	1.46e-05	8.15e-05	CcSEcCtD
Fluvastatin—Paraesthesia—Epirubicin—hematologic cancer	1.46e-05	8.14e-05	CcSEcCtD
Fluvastatin—Hyperhidrosis—Doxorubicin—hematologic cancer	1.45e-05	8.11e-05	CcSEcCtD
Fluvastatin—Dyspnoea—Epirubicin—hematologic cancer	1.45e-05	8.08e-05	CcSEcCtD
Fluvastatin—Anorexia—Doxorubicin—hematologic cancer	1.43e-05	8e-05	CcSEcCtD
Fluvastatin—Feeling abnormal—Methotrexate—hematologic cancer	1.43e-05	7.98e-05	CcSEcCtD
Fluvastatin—Dyspepsia—Epirubicin—hematologic cancer	1.43e-05	7.98e-05	CcSEcCtD
Fluvastatin—Diarrhoea—Prednisone—hematologic cancer	1.42e-05	7.93e-05	CcSEcCtD
Fluvastatin—Gastrointestinal pain—Methotrexate—hematologic cancer	1.42e-05	7.92e-05	CcSEcCtD
Fluvastatin—Nausea—Dexamethasone—hematologic cancer	1.41e-05	7.91e-05	CcSEcCtD
Fluvastatin—Nausea—Betamethasone—hematologic cancer	1.41e-05	7.91e-05	CcSEcCtD
Fluvastatin—Decreased appetite—Epirubicin—hematologic cancer	1.41e-05	7.88e-05	CcSEcCtD
Fluvastatin—Gastrointestinal disorder—Epirubicin—hematologic cancer	1.4e-05	7.83e-05	CcSEcCtD
Fluvastatin—Fatigue—Epirubicin—hematologic cancer	1.4e-05	7.82e-05	CcSEcCtD
Fluvastatin—Constipation—Epirubicin—hematologic cancer	1.39e-05	7.75e-05	CcSEcCtD
Fluvastatin—Pain—Epirubicin—hematologic cancer	1.39e-05	7.75e-05	CcSEcCtD
Fluvastatin—Urticaria—Methotrexate—hematologic cancer	1.38e-05	7.7e-05	CcSEcCtD
Fluvastatin—Dizziness—Prednisone—hematologic cancer	1.37e-05	7.67e-05	CcSEcCtD
Fluvastatin—Abdominal pain—Methotrexate—hematologic cancer	1.37e-05	7.66e-05	CcSEcCtD
Fluvastatin—Body temperature increased—Methotrexate—hematologic cancer	1.37e-05	7.66e-05	CcSEcCtD
Fluvastatin—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.37e-05	7.64e-05	CcSEcCtD
Fluvastatin—Insomnia—Doxorubicin—hematologic cancer	1.36e-05	7.59e-05	CcSEcCtD
Fluvastatin—Paraesthesia—Doxorubicin—hematologic cancer	1.35e-05	7.53e-05	CcSEcCtD
Fluvastatin—Dyspnoea—Doxorubicin—hematologic cancer	1.34e-05	7.48e-05	CcSEcCtD
Fluvastatin—Feeling abnormal—Epirubicin—hematologic cancer	1.34e-05	7.47e-05	CcSEcCtD
Fluvastatin—Gastrointestinal pain—Epirubicin—hematologic cancer	1.33e-05	7.41e-05	CcSEcCtD
Fluvastatin—Dyspepsia—Doxorubicin—hematologic cancer	1.32e-05	7.39e-05	CcSEcCtD
Fluvastatin—Vomiting—Prednisone—hematologic cancer	1.32e-05	7.37e-05	CcSEcCtD
Fluvastatin—Rash—Prednisone—hematologic cancer	1.31e-05	7.31e-05	CcSEcCtD
Fluvastatin—Dermatitis—Prednisone—hematologic cancer	1.31e-05	7.3e-05	CcSEcCtD
Fluvastatin—Decreased appetite—Doxorubicin—hematologic cancer	1.3e-05	7.29e-05	CcSEcCtD
Fluvastatin—Headache—Prednisone—hematologic cancer	1.3e-05	7.26e-05	CcSEcCtD
Fluvastatin—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.3e-05	7.24e-05	CcSEcCtD
Fluvastatin—Fatigue—Doxorubicin—hematologic cancer	1.29e-05	7.23e-05	CcSEcCtD
Fluvastatin—Urticaria—Epirubicin—hematologic cancer	1.29e-05	7.2e-05	CcSEcCtD
Fluvastatin—Pain—Doxorubicin—hematologic cancer	1.28e-05	7.17e-05	CcSEcCtD
Fluvastatin—Constipation—Doxorubicin—hematologic cancer	1.28e-05	7.17e-05	CcSEcCtD
Fluvastatin—Abdominal pain—Epirubicin—hematologic cancer	1.28e-05	7.17e-05	CcSEcCtD
Fluvastatin—Body temperature increased—Epirubicin—hematologic cancer	1.28e-05	7.17e-05	CcSEcCtD
Fluvastatin—Hypersensitivity—Methotrexate—hematologic cancer	1.28e-05	7.14e-05	CcSEcCtD
Fluvastatin—Asthenia—Methotrexate—hematologic cancer	1.24e-05	6.95e-05	CcSEcCtD
Fluvastatin—Feeling abnormal—Doxorubicin—hematologic cancer	1.24e-05	6.91e-05	CcSEcCtD
Fluvastatin—Nausea—Prednisone—hematologic cancer	1.23e-05	6.89e-05	CcSEcCtD
Fluvastatin—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.23e-05	6.86e-05	CcSEcCtD
Fluvastatin—Pruritus—Methotrexate—hematologic cancer	1.23e-05	6.86e-05	CcSEcCtD
Fluvastatin—Hypersensitivity—Epirubicin—hematologic cancer	1.19e-05	6.68e-05	CcSEcCtD
Fluvastatin—Urticaria—Doxorubicin—hematologic cancer	1.19e-05	6.67e-05	CcSEcCtD
Fluvastatin—Body temperature increased—Doxorubicin—hematologic cancer	1.19e-05	6.63e-05	CcSEcCtD
Fluvastatin—Abdominal pain—Doxorubicin—hematologic cancer	1.19e-05	6.63e-05	CcSEcCtD
Fluvastatin—Diarrhoea—Methotrexate—hematologic cancer	1.19e-05	6.63e-05	CcSEcCtD
Fluvastatin—Asthenia—Epirubicin—hematologic cancer	1.16e-05	6.51e-05	CcSEcCtD
Fluvastatin—Pruritus—Epirubicin—hematologic cancer	1.15e-05	6.42e-05	CcSEcCtD
Fluvastatin—Dizziness—Methotrexate—hematologic cancer	1.15e-05	6.41e-05	CcSEcCtD
Fluvastatin—Diarrhoea—Epirubicin—hematologic cancer	1.11e-05	6.2e-05	CcSEcCtD
Fluvastatin—Hypersensitivity—Doxorubicin—hematologic cancer	1.11e-05	6.18e-05	CcSEcCtD
Fluvastatin—Vomiting—Methotrexate—hematologic cancer	1.1e-05	6.16e-05	CcSEcCtD
Fluvastatin—Rash—Methotrexate—hematologic cancer	1.09e-05	6.11e-05	CcSEcCtD
Fluvastatin—Dermatitis—Methotrexate—hematologic cancer	1.09e-05	6.1e-05	CcSEcCtD
Fluvastatin—Headache—Methotrexate—hematologic cancer	1.09e-05	6.07e-05	CcSEcCtD
Fluvastatin—Asthenia—Doxorubicin—hematologic cancer	1.08e-05	6.02e-05	CcSEcCtD
Fluvastatin—Dizziness—Epirubicin—hematologic cancer	1.07e-05	6e-05	CcSEcCtD
Fluvastatin—Pruritus—Doxorubicin—hematologic cancer	1.06e-05	5.94e-05	CcSEcCtD
Fluvastatin—Vomiting—Epirubicin—hematologic cancer	1.03e-05	5.77e-05	CcSEcCtD
Fluvastatin—Nausea—Methotrexate—hematologic cancer	1.03e-05	5.76e-05	CcSEcCtD
Fluvastatin—Diarrhoea—Doxorubicin—hematologic cancer	1.03e-05	5.74e-05	CcSEcCtD
Fluvastatin—Rash—Epirubicin—hematologic cancer	1.02e-05	5.72e-05	CcSEcCtD
Fluvastatin—Dermatitis—Epirubicin—hematologic cancer	1.02e-05	5.71e-05	CcSEcCtD
Fluvastatin—Headache—Epirubicin—hematologic cancer	1.02e-05	5.68e-05	CcSEcCtD
Fluvastatin—Dizziness—Doxorubicin—hematologic cancer	9.92e-06	5.55e-05	CcSEcCtD
Fluvastatin—Nausea—Epirubicin—hematologic cancer	9.63e-06	5.39e-05	CcSEcCtD
Fluvastatin—Vomiting—Doxorubicin—hematologic cancer	9.54e-06	5.33e-05	CcSEcCtD
Fluvastatin—Rash—Doxorubicin—hematologic cancer	9.46e-06	5.29e-05	CcSEcCtD
Fluvastatin—Dermatitis—Doxorubicin—hematologic cancer	9.45e-06	5.29e-05	CcSEcCtD
Fluvastatin—Headache—Doxorubicin—hematologic cancer	9.4e-06	5.26e-05	CcSEcCtD
Fluvastatin—Nausea—Doxorubicin—hematologic cancer	8.91e-06	4.98e-05	CcSEcCtD
Fluvastatin—CYP3A4—Metabolism—HMMR—hematologic cancer	3.09e-06	4.93e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—GSTT1—hematologic cancer	3.09e-06	4.93e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.09e-06	4.93e-05	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism—PTEN—hematologic cancer	3.08e-06	4.91e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—SDC1—hematologic cancer	3.04e-06	4.86e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	3.04e-06	4.85e-05	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—GSTP1—hematologic cancer	3.04e-06	4.84e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—ALOX5—hematologic cancer	3.03e-06	4.84e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—SDC1—hematologic cancer	3.02e-06	4.82e-05	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—PIK3CD—hematologic cancer	3e-06	4.78e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	2.99e-06	4.76e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—CYCS—hematologic cancer	2.98e-06	4.76e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—HSP90AA1—hematologic cancer	2.96e-06	4.73e-05	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—ALB—hematologic cancer	2.96e-06	4.72e-05	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—ABCB1—hematologic cancer	2.94e-06	4.69e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—NUP98—hematologic cancer	2.94e-06	4.69e-05	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism—EP300—hematologic cancer	2.93e-06	4.68e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.91e-06	4.64e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—ARNTL—hematologic cancer	2.9e-06	4.63e-05	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—CREBBP—hematologic cancer	2.9e-06	4.62e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	2.88e-06	4.6e-05	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—ABCB1—hematologic cancer	2.87e-06	4.59e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—GSTP1—hematologic cancer	2.87e-06	4.58e-05	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—NCOR1—hematologic cancer	2.85e-06	4.55e-05	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—GSTM1—hematologic cancer	2.85e-06	4.55e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—NCOA3—hematologic cancer	2.85e-06	4.55e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—ADCY7—hematologic cancer	2.85e-06	4.55e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	2.85e-06	4.54e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—NUP214—hematologic cancer	2.83e-06	4.52e-05	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—PIK3R1—hematologic cancer	2.83e-06	4.51e-05	CbGpPWpGaD
Fluvastatin—HMGCR—Metabolism—PIK3CA—hematologic cancer	2.83e-06	4.51e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—ACP5—hematologic cancer	2.82e-06	4.51e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—CA9—hematologic cancer	2.82e-06	4.51e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—CD44—hematologic cancer	2.81e-06	4.49e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—NQO1—hematologic cancer	2.81e-06	4.49e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	2.8e-06	4.47e-05	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—GSTM1—hematologic cancer	2.79e-06	4.45e-05	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—NCOR1—hematologic cancer	2.79e-06	4.45e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—NCOR2—hematologic cancer	2.79e-06	4.45e-05	CbGpPWpGaD
Fluvastatin—UGT2B7—Metabolism—PTEN—hematologic cancer	2.78e-06	4.43e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.77e-06	4.43e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—MTR—hematologic cancer	2.77e-06	4.43e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—ABCG2—hematologic cancer	2.77e-06	4.43e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	2.76e-06	4.4e-05	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—PIK3CD—hematologic cancer	2.74e-06	4.38e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	2.72e-06	4.34e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—ENO2—hematologic cancer	2.72e-06	4.34e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—ABCB1—hematologic cancer	2.71e-06	4.33e-05	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—ALB—hematologic cancer	2.71e-06	4.32e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.67e-06	4.26e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—CYCS—hematologic cancer	2.66e-06	4.25e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—IDH1—hematologic cancer	2.66e-06	4.24e-05	CbGpPWpGaD
Fluvastatin—UGT2B7—Metabolism—EP300—hematologic cancer	2.65e-06	4.23e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	2.65e-06	4.22e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—GSTT1—hematologic cancer	2.64e-06	4.21e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—GSTM1—hematologic cancer	2.64e-06	4.21e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—NCOR1—hematologic cancer	2.64e-06	4.21e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—GSTP1—hematologic cancer	2.63e-06	4.2e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—GSTO1—hematologic cancer	2.63e-06	4.19e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—ABCC3—hematologic cancer	2.63e-06	4.19e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—TXN—hematologic cancer	2.63e-06	4.19e-05	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—PIK3CB—hematologic cancer	2.61e-06	4.17e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	2.6e-06	4.15e-05	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—PIK3R1—hematologic cancer	2.59e-06	4.14e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—NQO1—hematologic cancer	2.59e-06	4.13e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—CD44—hematologic cancer	2.59e-06	4.13e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—SDC1—hematologic cancer	2.58e-06	4.12e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—SPHK1—hematologic cancer	2.57e-06	4.1e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—NQO1—hematologic cancer	2.57e-06	4.09e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—CD44—hematologic cancer	2.57e-06	4.09e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.54e-06	4.06e-05	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—MTHFR—hematologic cancer	2.52e-06	4.03e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	2.51e-06	4.01e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—ABCB1—hematologic cancer	2.49e-06	3.97e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—UGT1A1—hematologic cancer	2.47e-06	3.94e-05	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—MTHFR—hematologic cancer	2.47e-06	3.93e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	2.46e-06	3.93e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—CYCS—hematologic cancer	2.45e-06	3.91e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	2.43e-06	3.88e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	2.43e-06	3.88e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—CYCS—hematologic cancer	2.43e-06	3.87e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—GSTM1—hematologic cancer	2.42e-06	3.86e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—NCOR1—hematologic cancer	2.42e-06	3.86e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	2.41e-06	3.85e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—CRABP1—hematologic cancer	2.4e-06	3.83e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—SLC22A1—hematologic cancer	2.4e-06	3.83e-05	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—PIK3CB—hematologic cancer	2.39e-06	3.82e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.38e-06	3.8e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—GSTP1—hematologic cancer	2.35e-06	3.75e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—ALOX5—hematologic cancer	2.34e-06	3.74e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—MTHFR—hematologic cancer	2.33e-06	3.72e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	2.33e-06	3.71e-05	CbGpPWpGaD
Fluvastatin—HMGCR—Metabolism—AKT1—hematologic cancer	2.31e-06	3.68e-05	CbGpPWpGaD
Fluvastatin—UGT1A3—Metabolism—PIK3CA—hematologic cancer	2.3e-06	3.68e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.27e-06	3.62e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—NUP98—hematologic cancer	2.27e-06	3.62e-05	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—PTEN—hematologic cancer	2.26e-06	3.6e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—ABCB1—hematologic cancer	2.22e-06	3.55e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—ADCY7—hematologic cancer	2.2e-06	3.51e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—NCOA3—hematologic cancer	2.2e-06	3.51e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—CD44—hematologic cancer	2.19e-06	3.5e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—NQO1—hematologic cancer	2.19e-06	3.5e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—NUP214—hematologic cancer	2.19e-06	3.49e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.17e-06	3.46e-05	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism—PIK3CA—hematologic cancer	2.17e-06	3.46e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—GSTP1—hematologic cancer	2.16e-06	3.44e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—NCOR1—hematologic cancer	2.16e-06	3.44e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—GSTM1—hematologic cancer	2.16e-06	3.44e-05	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—EP300—hematologic cancer	2.15e-06	3.43e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	2.15e-06	3.43e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—MTR—hematologic cancer	2.14e-06	3.42e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—ABCG2—hematologic cancer	2.14e-06	3.42e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—GSTP1—hematologic cancer	2.14e-06	3.42e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—MTHFR—hematologic cancer	2.14e-06	3.41e-05	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—PIK3CG—hematologic cancer	2.12e-06	3.38e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—ENO2—hematologic cancer	2.1e-06	3.35e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—CYCS—hematologic cancer	2.07e-06	3.31e-05	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—PIK3CG—hematologic cancer	2.07e-06	3.31e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.07e-06	3.3e-05	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—PTEN—hematologic cancer	2.07e-06	3.3e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	2.06e-06	3.29e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.05e-06	3.28e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—ABCB1—hematologic cancer	2.04e-06	3.26e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—GSTT1—hematologic cancer	2.04e-06	3.25e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—ABCB1—hematologic cancer	2.03e-06	3.23e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—SDC1—hematologic cancer	1.99e-06	3.18e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—GSTM1—hematologic cancer	1.98e-06	3.17e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—NCOR1—hematologic cancer	1.98e-06	3.17e-05	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—EP300—hematologic cancer	1.97e-06	3.15e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—GSTM1—hematologic cancer	1.97e-06	3.14e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—NCOR1—hematologic cancer	1.97e-06	3.14e-05	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—CREBBP—hematologic cancer	1.96e-06	3.14e-05	CbGpPWpGaD
Fluvastatin—UGT2B7—Metabolism—PIK3CA—hematologic cancer	1.96e-06	3.13e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—PIK3CG—hematologic cancer	1.96e-06	3.12e-05	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—CREBBP—hematologic cancer	1.92e-06	3.06e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—MTHFR—hematologic cancer	1.91e-06	3.04e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.88e-06	3e-05	CbGpPWpGaD
Fluvastatin—UGT1A3—Metabolism—AKT1—hematologic cancer	1.88e-06	3e-05	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—PIK3CD—hematologic cancer	1.86e-06	2.97e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.86e-06	2.96e-05	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—ALB—hematologic cancer	1.84e-06	2.94e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—GSTP1—hematologic cancer	1.83e-06	2.92e-05	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—PIK3CD—hematologic cancer	1.82e-06	2.91e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—CREBBP—hematologic cancer	1.81e-06	2.9e-05	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—ALB—hematologic cancer	1.8e-06	2.87e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—PIK3CG—hematologic cancer	1.79e-06	2.86e-05	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism—AKT1—hematologic cancer	1.77e-06	2.83e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.77e-06	2.82e-05	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—PIK3R1—hematologic cancer	1.76e-06	2.81e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—MTHFR—hematologic cancer	1.75e-06	2.8e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—MTHFR—hematologic cancer	1.74e-06	2.77e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—ABCB1—hematologic cancer	1.73e-06	2.76e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—PIK3CD—hematologic cancer	1.72e-06	2.75e-05	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—PIK3R1—hematologic cancer	1.72e-06	2.74e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—ALB—hematologic cancer	1.7e-06	2.71e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—NQO1—hematologic cancer	1.69e-06	2.7e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—CD44—hematologic cancer	1.69e-06	2.7e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—NCOR1—hematologic cancer	1.68e-06	2.68e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—GSTM1—hematologic cancer	1.68e-06	2.68e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.68e-06	2.68e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—CREBBP—hematologic cancer	1.66e-06	2.65e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—PIK3R1—hematologic cancer	1.62e-06	2.59e-05	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—PIK3CB—hematologic cancer	1.62e-06	2.59e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—PIK3CG—hematologic cancer	1.6e-06	2.56e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—CYCS—hematologic cancer	1.6e-06	2.56e-05	CbGpPWpGaD
Fluvastatin—UGT2B7—Metabolism—AKT1—hematologic cancer	1.6e-06	2.55e-05	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—PIK3CA—hematologic cancer	1.59e-06	2.54e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	1.59e-06	2.54e-05	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—PIK3CB—hematologic cancer	1.59e-06	2.53e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—PIK3CD—hematologic cancer	1.58e-06	2.52e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—ALB—hematologic cancer	1.56e-06	2.48e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.53e-06	2.44e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—PIK3CB—hematologic cancer	1.5e-06	2.39e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—PIK3R1—hematologic cancer	1.49e-06	2.38e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—MTHFR—hematologic cancer	1.49e-06	2.37e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—CREBBP—hematologic cancer	1.48e-06	2.37e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—PIK3CG—hematologic cancer	1.47e-06	2.35e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—PIK3CG—hematologic cancer	1.46e-06	2.33e-05	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—PIK3CA—hematologic cancer	1.46e-06	2.33e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—GSTP1—hematologic cancer	1.41e-06	2.25e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—PIK3CD—hematologic cancer	1.41e-06	2.25e-05	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—PTEN—hematologic cancer	1.4e-06	2.24e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—ALB—hematologic cancer	1.39e-06	2.22e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—PIK3CB—hematologic cancer	1.37e-06	2.19e-05	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—PTEN—hematologic cancer	1.37e-06	2.19e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—CREBBP—hematologic cancer	1.37e-06	2.18e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—CREBBP—hematologic cancer	1.35e-06	2.16e-05	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—EP300—hematologic cancer	1.34e-06	2.14e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—ABCB1—hematologic cancer	1.34e-06	2.13e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—PIK3R1—hematologic cancer	1.33e-06	2.12e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.31e-06	2.09e-05	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—EP300—hematologic cancer	1.31e-06	2.09e-05	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—AKT1—hematologic cancer	1.3e-06	2.07e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.3e-06	2.07e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.3e-06	2.07e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—PTEN—hematologic cancer	1.3e-06	2.07e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—PIK3CD—hematologic cancer	1.29e-06	2.07e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—PIK3CD—hematologic cancer	1.28e-06	2.05e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—ALB—hematologic cancer	1.28e-06	2.04e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—ALB—hematologic cancer	1.27e-06	2.02e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—PIK3CG—hematologic cancer	1.25e-06	1.99e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—EP300—hematologic cancer	1.24e-06	1.97e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—PIK3CB—hematologic cancer	1.23e-06	1.96e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—PIK3R1—hematologic cancer	1.22e-06	1.95e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—PIK3R1—hematologic cancer	1.21e-06	1.93e-05	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—AKT1—hematologic cancer	1.19e-06	1.9e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—PTEN—hematologic cancer	1.19e-06	1.9e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—CREBBP—hematologic cancer	1.16e-06	1.85e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.15e-06	1.83e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—EP300—hematologic cancer	1.13e-06	1.81e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—PIK3CB—hematologic cancer	1.13e-06	1.8e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—PIK3CB—hematologic cancer	1.12e-06	1.79e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—PIK3CD—hematologic cancer	1.1e-06	1.75e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—ALB—hematologic cancer	1.08e-06	1.73e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—PTEN—hematologic cancer	1.06e-06	1.69e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—PIK3R1—hematologic cancer	1.04e-06	1.65e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—EP300—hematologic cancer	1.01e-06	1.61e-05	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—PIK3CA—hematologic cancer	9.9e-07	1.58e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—PTEN—hematologic cancer	9.75e-07	1.56e-05	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—PIK3CA—hematologic cancer	9.68e-07	1.54e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—PTEN—hematologic cancer	9.67e-07	1.54e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—PIK3CG—hematologic cancer	9.63e-07	1.54e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—PIK3CB—hematologic cancer	9.56e-07	1.53e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—EP300—hematologic cancer	9.3e-07	1.48e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—EP300—hematologic cancer	9.22e-07	1.47e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—PIK3CA—hematologic cancer	9.14e-07	1.46e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—CREBBP—hematologic cancer	8.93e-07	1.42e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—PIK3CD—hematologic cancer	8.47e-07	1.35e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—PIK3CA—hematologic cancer	8.38e-07	1.34e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—ALB—hematologic cancer	8.36e-07	1.33e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—PTEN—hematologic cancer	8.26e-07	1.32e-05	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—AKT1—hematologic cancer	8.09e-07	1.29e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—PIK3R1—hematologic cancer	7.99e-07	1.28e-05	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—AKT1—hematologic cancer	7.9e-07	1.26e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—EP300—hematologic cancer	7.88e-07	1.26e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—PIK3CA—hematologic cancer	7.48e-07	1.19e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—AKT1—hematologic cancer	7.47e-07	1.19e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—PIK3CB—hematologic cancer	7.38e-07	1.18e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—PIK3CA—hematologic cancer	6.88e-07	1.1e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—AKT1—hematologic cancer	6.85e-07	1.09e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—PIK3CA—hematologic cancer	6.82e-07	1.09e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—PTEN—hematologic cancer	6.38e-07	1.02e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—AKT1—hematologic cancer	6.11e-07	9.75e-06	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—EP300—hematologic cancer	6.08e-07	9.7e-06	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—PIK3CA—hematologic cancer	5.83e-07	9.3e-06	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—AKT1—hematologic cancer	5.62e-07	8.97e-06	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—AKT1—hematologic cancer	5.57e-07	8.89e-06	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—AKT1—hematologic cancer	4.76e-07	7.6e-06	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—PIK3CA—hematologic cancer	4.5e-07	7.18e-06	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—AKT1—hematologic cancer	3.67e-07	5.86e-06	CbGpPWpGaD
